Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 3, 2008, Pages 1062-1065

  Cuenca Estrella, Manuel ^a,b   Gomez Lopez, Alicia ^a   Gutierrez, M Olga ^a   Buitrago, M Jose ^a   Rodriguez Tudela, Juan L ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; VORICONAZOLE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA; CANDIDA ALBICANS; CANDIDA FAMATA; CANDIDA GLABRATA; CANDIDA GUILLIERMONDII; CANDIDA HAEMULONII; CANDIDA LUSITANIAE; CANDIDA PARAPSILOSIS; CANDIDA PELLICULOSA; CANDIDA TROPICALIS; CONTROLLED STUDY; CRYPTOCOCCUS; CRYPTOCOCCUS NEOFORMANS; DEVICE; DILUTION; DIPODASCUS CAPITATUS; FUNGAL STRAIN; FUNGUS GROWTH; FUNGUS ISOLATION; IMAGE PROCESSING; IMAGING SYSTEM; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PICHIA; PICHIA MEMBRANIFACIENS; PRIORITY JOURNAL; RHODOTORULA; RHODOTORULA MUCILAGINOSA; SACCHAROMYCES CEREVISIAE; STANDARD; YEAST;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; AZOLES; CANDIDA; CULTURE MEDIA; DRUG RESISTANCE, FUNGAL; FUNGI; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOSES; REPRODUCIBILITY OF RESULTS; YEASTS;

EID: 40549138412     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01016-07     Document Type: Article

References (16)

1. Barry, A. L., M. A. Pfaller, S. D. Brown, A. Espinel-Ingroff, M. A. Ghannoum, C. Knapp, R. P. Rennie, J. H. Rex, and M. G. Rinaldi. 2000. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents. J. Clin. Microbiol. 38:3457-3459.
2. Cantón, R., M. Pérez-Vázquez, A. Oliver, B. Sánchez Del Saz, M. O. Gutiérrez, M. Martínez-Ferrer, and F. Baquero. 2000. Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J. Clin. Microbiol. 38:1339-1346.
3. Chryssanthou, E., and M. Cuenca-Estrella. 2002. Comparison of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antibiotic Susceptibility Testing proposed standard and the E-test with the NCCLS broth microdilution method for voriconazole and caspofungin susceptibility testing of yeast species. J. Clin. Microbiol. 40:3841-3844.
4. Cuenca-Estrella, M., T. M. Díaz-Guerra, E. Mellado, and J. L. Rodríguez-Tudela. 2001. Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp. J. Clin. Microbiol. 39:525-532.
5. Cuenca-Estrella, M., A. Gomez-Lopez, E. Mellado, and J. L. Rodriguez-Tudela. 2005. Correlation between the procedure for antifungal susceptibility testing for Candida spp. of the European Committee on Antibiotic Susceptibility Testing (EUCAST) and four commercial techniques. Clin. Microbiol. Infect. 11:486-492.
6. Cuenca-Estrella, M., W. Lee-Yang, M. A. Ciblak, B. A. Arthington-Skaggs, E. Mellado, D. W. Warnock, and J. L. Rodriguez-Tudela. 2002. Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species. Antimicrob. Agents Chemother. 46:3644-3647.
7. Cuenca-Estrella, M., C. B. Moore, F. Barchiesi, J. Bille, E. Chryssanthou, D. W. Denning, J. P. Donnelly, F. Dromer, B. Dupont, J. H. Rex, M. D. Richardson, B. Sancak, P. E. Verweij, and J. L. Rodriguez-Tudela. 2003. Multicenter evaluation of the reproducibility of the proposed antifungal susceptibility testing method for fermentative yeasts of the Antifungal Susceptibility Testing Subcommittee of the European Committee on Antimicrobial Susceptibility Testing (AFST-EUCAST). Clin. Microbiol. Infect. 9:467-474.
8. de Hoog, G. S., J. Guarro, J. Gene, and M. J. Figueres. 2000. Atlas of clinical fungi. Universitat Rovira i Virgili, Reus, Spain.
9. Espinel-Ingroff, A., F. Barchiesi, M. Cuenca-Estrella, M. A. Pfaller, M. Rinaldi, J. L. Rodriguez-Tudela, and P. E. Verweij. 2005. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole. J. Clin. Microbiol. 43:3884-3889.
10. Kurtzman, C. P., and J. W. Fell (ed.). 1998. The yeasts, a taxonomic study, 4th ed. Elsevier, Amsterdam, The Netherlands.
11. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of yeast; approved standard, 2nd ed. NCCLS document M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
12. Pfaller, M. A., D. J. Diekema, G. W. Procop, and M. G. Rinaldi. 2007. Multicenter comparison of the VITEK 2 yeast susceptibility test with the CLSI broth microdilution reference method for testing fluconazole against Candida spp. J. Clin. Microbiol. 45:796-802.
13. Pfaller, M. A., S. A. Messer, R. J. Hollis, and R. N. Jones. 2001. In vitro activities of posaconazole (Sch 56592) compared with those of itraconazole and fluconazole against 3,685 clinical isolates of Candida spp. and Cryptococcus neoformans. Antimicrob. Agents Chemother. 45:2862-2864.
14. Rodríguez-Tudela, J. L., F. Martín-Díez, M. Cuenca-Estrella, L. Rodero, Y. Carpintero, and B. Gorgojo. 2000. Influence of shaking on antifungal susceptibility testing of Cryptococcus neoformans: a comparison of the NCCLS standard M27A medium, buffered yeast nitrogen base, and RPMI-2% glucose. Antimicrob. Agents Chemother. 44:400-404.
15. Rodríguez-Tudela, J. L., M. Cuenca-Estrella, T. M. Díaz-Guerra, and E. Mellado. 2001. Standardization of antifungal susceptibility variables for a semiautomated methodology. J. Clin. Microbiol. 39:2513-2517.
16. Rodriguez-Tudela, J. L., J. P. Donnelly, M. A. Pfaller, E. Chryssantou, P. Warn, D. W. Denning, A. Espinel-Ingroff, F. Barchiesi, and M. Cuenca-Estrella. 2007. Statistical analyses of correlation between fluconazole MICs for Candida spp. assessed by standard methods set forth by the European Committee on Antimicrobial Susceptibility Testing (E.Dis. 7.1) and CLSI (M27-A2). J. Clin. Microbiol. 45:109-111.